{"nct_id":"NCT06655818","title":"Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM","status":"TERMINATED","status_verified_date":"2025-02","start_date":"2021-03-09","start_date_type":"ACTUAL","primary_completion_date":"2024-02-14","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-14","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}